Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W0XK
|
||||
| Former ID |
DNC009203
|
||||
| Drug Name |
(+/-)-3-(pent-4-enyl)azetidin-2-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529529] | ||
| Formula |
C8H13NO
|
||||
| Canonical SMILES |
C=CCCCC1CNC1=O
|
||||
| InChI |
1S/C8H13NO/c1-2-3-4-5-7-6-9-8(7)10/h2,7H,1,3-6H2,(H,9,10)
|
||||
| InChIKey |
ABPZGIHKPZCCMN-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529529] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.